Showing 1 to 12 of 70 results
French Surgeons Restore Sight Using Tooth-Based Implant
In Montpellier, France, surgeons performed a pioneering operation using a tooth implant to restore the sight of Dylan, 24, who had been blind since age 12 due to a severe allergic reaction.
French Surgeons Restore Sight Using Tooth-Based Implant
In Montpellier, France, surgeons performed a pioneering operation using a tooth implant to restore the sight of Dylan, 24, who had been blind since age 12 due to a severe allergic reaction.
Progress
44% Bias Score
Nine-Day Success of Pig Lung Transplant in Brain-Dead Man
A 39-year-old brain-dead man received a genetically modified pig lung transplant, which functioned for nine days before rejection, highlighting both the potential and significant challenges of xenotransplantation for addressing organ shortages.
Nine-Day Success of Pig Lung Transplant in Brain-Dead Man
A 39-year-old brain-dead man received a genetically modified pig lung transplant, which functioned for nine days before rejection, highlighting both the potential and significant challenges of xenotransplantation for addressing organ shortages.
Progress
40% Bias Score
Weekly Parkinson's Injection Shows Promise
Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.
Weekly Parkinson's Injection Shows Promise
Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.
Progress
52% Bias Score
Gene Therapy Restores Sight in Usher Syndrome Patient
A 38-year-old Italian man with Usher syndrome type 1b regained his sight after an experimental gene therapy at the University of Campania in July 2024; seven more patients underwent the procedure, showing promising results and paving the way for broader application.
Gene Therapy Restores Sight in Usher Syndrome Patient
A 38-year-old Italian man with Usher syndrome type 1b regained his sight after an experimental gene therapy at the University of Campania in July 2024; seven more patients underwent the procedure, showing promising results and paving the way for broader application.
Progress
20% Bias Score
Metastatic Melanoma: Aggressive Treatment Yields Positive Results
Jennifer Frederick, 50, was diagnosed with metastatic malignant melanoma after discovering a lump in her groin; despite aggressive treatment causing severe side effects, scans show major improvement, highlighting advancements in immunotherapy and offering hope for long-term survival.
Metastatic Melanoma: Aggressive Treatment Yields Positive Results
Jennifer Frederick, 50, was diagnosed with metastatic malignant melanoma after discovering a lump in her groin; despite aggressive treatment causing severe side effects, scans show major improvement, highlighting advancements in immunotherapy and offering hope for long-term survival.
Progress
40% Bias Score
Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Universal Cancer Vaccine Shows Promise in Mice Studies
A new mRNA-based cancer vaccine, tested on mice with various cancers, demonstrates potential as a universal treatment, shrinking or eliminating tumors when combined with immunotherapy, improving survival rates significantly; however, human trials are still needed.
Progress
52% Bias Score
Pig Lung Successfully Transplanted into Human for Nine Days
Chinese surgeons successfully transplanted a pig lung into a brain-dead patient; the lung functioned for nine days before the patient was removed from life support, showcasing progress but also highlighting challenges in xenotransplantation.
Pig Lung Successfully Transplanted into Human for Nine Days
Chinese surgeons successfully transplanted a pig lung into a brain-dead patient; the lung functioned for nine days before the patient was removed from life support, showcasing progress but also highlighting challenges in xenotransplantation.
Progress
36% Bias Score
Successful Pig-to-Human Lung Transplant Achieved
Chinese surgeons successfully transplanted a genetically modified pig lung into a brain-dead human, maintaining its viability for nine days before immune rejection; this pioneering study, published in Nature Medicine, demonstrates progress in xenotransplantation to address organ shortages.
Successful Pig-to-Human Lung Transplant Achieved
Chinese surgeons successfully transplanted a genetically modified pig lung into a brain-dead human, maintaining its viability for nine days before immune rejection; this pioneering study, published in Nature Medicine, demonstrates progress in xenotransplantation to address organ shortages.
Progress
40% Bias Score
Baby Born from 30-Year-Old Frozen Embryo
A 35-year-old Ohio woman gave birth to a baby boy on Saturday from an embryo frozen for over 30 years, highlighting the success of embryo adoption and raising ethical questions about long-term embryo viability and adoption practices.
Baby Born from 30-Year-Old Frozen Embryo
A 35-year-old Ohio woman gave birth to a baby boy on Saturday from an embryo frozen for over 30 years, highlighting the success of embryo adoption and raising ethical questions about long-term embryo viability and adoption practices.
Progress
60% Bias Score
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Progress
48% Bias Score
Three-Person IVF Shows Promise, But Long-Term Risks Remain
A UK study of eight babies born via a three-person IVF technique, involving mitochondrial donation from a donor to prevent mitochondrial disease transmission, shows a significant reduction in mutated mitochondrial DNA in six babies (95–100%) and below disease-causing levels in two more, although lon...
Three-Person IVF Shows Promise, But Long-Term Risks Remain
A UK study of eight babies born via a three-person IVF technique, involving mitochondrial donation from a donor to prevent mitochondrial disease transmission, shows a significant reduction in mutated mitochondrial DNA in six babies (95–100%) and below disease-causing levels in two more, although lon...
Progress
40% Bias Score
Three-Person IVF Successfully Prevents Inherited Mitochondrial Disease in Eight Babies
Eight babies have been born in the UK using a three-person IVF method, preventing the transmission of severe, often fatal mitochondrial diseases from mother to child, offering hope to families affected by these conditions.
Three-Person IVF Successfully Prevents Inherited Mitochondrial Disease in Eight Babies
Eight babies have been born in the UK using a three-person IVF method, preventing the transmission of severe, often fatal mitochondrial diseases from mother to child, offering hope to families affected by these conditions.
Progress
60% Bias Score
Showing 1 to 12 of 70 results